AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

๐Ÿงช

Trial Match

Clinical trials test new treatments โ€” sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

๐ŸŽฏ Match trials to me

30 recruiting trials

for Breast Cancer, Metastatic

Genetically-informed Therapy for ER+ Breast Cancer Post-CDK4/6 Inhibitor NCT05933395Phase 21 site๐Ÿ“ Lebanon Dartmouth-Hitchcock Medical Center ยท Tests: Fulvestrant, Neratinib, Alpelisib, Everolimus, Abemaciclib Elacestrant in Patients With ER+ HER2- ESR1-mutated Locally Advanced or Metastatic Breast Cancer NCT07563595n/a3 sites๐Ÿ“ Freiburg im Breisgau๐Ÿ“ Paderborn๐Ÿ“ Ravensburg iOMEDICO AG ยท Tests: Elacestrant, Standard of care (Investigator Choice) Study Evaluating DNA Double-strand Breaks (DSBs) REpair Factors (POLQ, Shieldin Complex and 53BP1) Expression as Biomarker of PARP Inhibitor Resistance in Patients With Deleterious Germline Mutation in BRCA 1/2 and HER2-negative, Metastatic or Locally Advanced Breast Cancer. NCT05378204NA25 sites๐Ÿ“ Bordeaux๐Ÿ“ Caen๐Ÿ“ Clermont-Ferrand Institut Claudius Regaud ยท Tests: Main study:, Sub-study: Breast Cancer: Axillary Conservation After Neoadjuvant Chemotherapy in Micro Metastatic Sentinel Lymph Nodes. NCT04019678NA1 site๐Ÿ“ Rozzano Istituto Clinico Humanitas ยท Tests: Omission of Axillary dissection A Study of GNC-077 in Patients With Locally Advanced or Metastatic Breast Cancer and Other Solid Tumors NCT06609187Phase 11 site๐Ÿ“ Beijing Sichuan Baili Pharmaceutical Co., Ltd. ยท Tests: GNC-077 Phase II Single Arm Trial of Low Dose Capecitabine in Patients With Advanced Breast Cancer NCT06105684Phase 21 site๐Ÿ“ Birmingham University of Alabama at Birmingham ยท Tests: Capecitabine Pill A Phase I Interventional Open-label, Non-randomized Dose-escalation Trial to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, Immunogenicity, and Preliminary Anti-tumor Activity of Autologous p95HER2.CAR-TECH2Me T Cells in Patients With Selected Advanced Cancers. NCT07593820Phase 12 sites๐Ÿ“ Barcelona๐Ÿ“ Barcelona Vall d'Hebron Institute of Oncology ยท Tests: p95HER2.CAR-TECH2Me CTCs in Breast Cancer After Neoadjuvant Treatment and Surgery: a Multicenter, Prospective Clinical Trial NCT05360290NA1 site๐Ÿ“ Shanghai RenJi Hospital ยท Tests: GILUPI CellCollectorยฎ FDG PET-CT in Advanced Breast Cancer NCT07173868n/a1 site๐Ÿ“ Seoul Samsung Medical Center Metarrestin (ML-246) in Subjects With Metastatic Solid Tumors NCT04222413Phase 12 sites๐Ÿ“ Fairway๐Ÿ“ Bethesda National Cancer Institute (NCI) ยท Tests: Metarrestin Breast Cancer Organelle Properties and Protein Expression Atlas in the Three Immunohistochemical Subtypes of Breast Cancers NCT07233928NA1 site๐Ÿ“ Toulouse Institut Claudius Regaud ยท Tests: Tumor biopsy Brain [18F]-FES PET/CT in Patients With Estrogen-Receptor Positive Breast Cancer NCT06072807Phase 41 site๐Ÿ“ New York Weill Medical College of Cornell University ยท Tests: Brain Imaging with 18F-FES Efficacy and Safety of Intrathecal Administration of Thiotepa in Combination With Methotrexate in Breast Cancer With Leptomeningeal Metastasis NCT06543992Phase 21 site๐Ÿ“ Nanjing The First Affiliated Hospital with Nanjing Medical Universiโ€ฆ ยท Tests: Intrathecal Administration of Thiotepa in Combination with Methotrexate via the Ommaya Reservoir Utidelone Versus Docetaxel in HER2-negative Locally Advanced or Metastatic Breast Cancer NCT05430399Phase 32 sites๐Ÿ“ Guangzhou๐Ÿ“ Hunan Sun Yat-sen University ยท Tests: utidelone, docetaxel A Dose Randomization Study of Bulumtatug Fuvedotin in TNBC Patients Previously Treated With ADCs NCT06908928Phase 17 sites๐Ÿ“ Duarte๐Ÿ“ La Jolla๐Ÿ“ Aurora Mabwell (Shanghai) Bioscience Co., Ltd. ยท Tests: bulumtatug fuvedotin, bulumtatug fuvedotin Olaparib With Cediranib or AZD6738 for the Treatment of Advanced or Metastatic Germline BRCA Mutated Breast Cancer NCT04090567Phase 21 site๐Ÿ“ Houston M.D. Anderson Cancer Center ยท Tests: Cediranib, Ceralasertib, Olaparib Abemaciclib and Endocrine Therapy in Older Patients With Breast Cancer. NCT04305834Phase 26 sites๐Ÿ“ Duarte๐Ÿ“ Irvine๐Ÿ“ Long Beach City of Hope Medical Center ยท Tests: Abemaciclib, Questionnaire Administration The Clinical Study of the Efficacy and Safety of Trop2-ADC Monotherapy or Combination Immunotherapy Strategy in the Treatment of Advanced Triple-negative Breast Cancer. NCT06851299Phase 21 site๐Ÿ“ Guangzhou Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University ยท Tests: trop2-ADC, ADC +anti-angiogenic drug, ADC + PD1 monoclonal antibody +anti-angiogenic drug Phase II Study of Dato-DXd in Triple-negative Breast Cancer Patients With Newly Diagnosed or Progressing Brain Metastases NCT05866432Phase 21 site๐Ÿ“ Vienna Medical University of Vienna ยท Tests: Datopotamab deruxtecan Step Count and Treatment Response in Neoadjuvant Breast Cancer NCT07162675n/a2 sites๐Ÿ“ Ankara๐Ÿ“ Ankara Ankara Etlik City Hospital ยท Tests: Huawei Fit 2 Smartwatch Assessement of Potential Interest of [68Ga]Ga-PentixaFor PET/CT in Metastatic Triple Negative Breast Cancer Patients NCT06962163NA1 site๐Ÿ“ Saint-Herblain Institut Cancerologie de l'Ouest ยท Tests: [68Ga]Ga-PentixaFor PET/CT Level I-II Axillary Irradiation in Breast Cancer With Sentinel-Node Macro-metastases NCT07469267NA15 sites๐Ÿ“ Guiyang๐Ÿ“ Shijiazhuang๐Ÿ“ Harbin Fudan University ยท Tests: Entire regional nodal irradiation, Level I-II axillary irradiation Study in Patients With Breast Cancer Leptomeningeal Metastasis NCT06638294n/a2 sites๐Ÿ“ Washington D.C.๐Ÿ“ Baltimore Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Study of HRS-8080 or SHR-A2009 Combined With Anti-tumor Therapy in Patients With Unresectable or Metastatic Breast Cancer NCT06222879Phase 1, Phase 21 site๐Ÿ“ Changsha Shandong Suncadia Medicine Co., Ltd. ยท Tests: HRS-8080; SHR-A1811, HRS-8080; SHR-A2009, SHR-A2009; SHR-1316 A Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Patients With Metastatic or Locally Advanced Breast Cancer NCT03424005Phase 1, Phase 255 sites๐Ÿ“ Duarte๐Ÿ“ Duarte๐Ÿ“ Irvine Hoffmann-La Roche ยท Tests: Capecitabine, Atezolizumab, Ipatasertib, SGN-LIV1A, Bevacizumab Efficacy of Trastuzumab Deruxtecan in Metastatic Breast Cancer With Different HER2 Expression Patterns NCT06551220n/a26 sites๐Ÿ“ New Haven๐Ÿ“ Boston๐Ÿ“ Fuzhou Sun Yat-sen University ยท Tests: Trastuzumab Deruxtecan Tumor-Targeted-NIR-II Fluorescent Molecular Probes for the Identification of Breast Cancer Tissue and SLN Metastatic Status NCT06713161n/a1 site๐Ÿ“ Kunming Yunnan Cancer Hospital ยท Tests: NIR-II Probe(i.e ICG-POL6326) incubation solution A Study of Abemaciclib and Radiation Therapy in People With Metastatic Breast Cancer NCT06678269Phase 17 sites๐Ÿ“ Basking Ridge๐Ÿ“ Middletown๐Ÿ“ Montvale Memorial Sloan Kettering Cancer Center ยท Tests: Abemaciclib, Radiation Therapy A Study to Learn About the Study Medicine Called PF-08032562 in People With Advanced or Metastatic Solid Tumors NCT07318805Phase 113 sites๐Ÿ“ Duarte๐Ÿ“ Grand Rapids๐Ÿ“ Long Island City Pfizer ยท Tests: PF-08032562, Fulvestrant, Cetuximab, Fluorouracil, Oxaliplatin The Efficacy and Safety of Utidelone Plus Tirelizumab and Bevacizumab for Advanced or Metastatic Triple-negative Breast Cancer (UTILIZABLE) ๏ผšSingle-arm, Prospective, Open Clinical Study NCT06125080Phase 21 site๐Ÿ“ Wuhan Huihua Xiong ยท Tests: Utidelone, Tirelizumab, Bevacizumab
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy